Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 0 | 0 | 0 | 0 | 7,500 |
| Gross Profit | N/A | N/A | N/A | N/A | 7,500 |
| Operating Expenses | 38,133 | 34,419 | 38,522 | 44,538 | 36,143 |
| Operating Income | -38,133 | -34,419 | -38,522 | -44,538 | -28,643 |
| Other Income | 244 | 10 | 160 | 205 | 207 |
| Pre-tax Income | -37,889 | -34,409 | -38,362 | -44,333 | -28,436 |
| Income Tax | 19 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -37,908 | -34,409 | -38,362 | -44,333 | -28,436 |
| Net Income | $-37,908 | $-34,409 | $-38,362 | $-44,333 | $-28,436 |
| EPS Basic Total Ops | -3.80 | -3.50 | -3.90 | -4.50 | -2.90 |
| EPS Basic Continuous Ops | -3.84 | -3.50 | -3.91 | -4.52 | -2.91 |
| EPS Diluted Total Ops | -3.80 | -3.50 | -3.90 | -4.50 | -2.90 |
| EPS Diluted Continuous Ops | -3.84 | -3.50 | -3.91 | -4.52 | -2.91 |
| EBITDA(a) | $-36,496 | $-29,881 | $-36,685 | $-42,800 | $-26,622 |